agilon health, inc. (NYSE:AGL) Short Interest Down 7.4% in September

agilon health, inc. (NYSE:AGL - Get Free Report) was the recipient of a significant decline in short interest in September. As of September 30th, there was short interest totalling 36,490,000 shares, a decline of 7.4% from the September 15th total of 39,420,000 shares. Based on an average trading volume of 4,390,000 shares, the short-interest ratio is currently 8.3 days. Currently, 12.1% of the company's shares are sold short.

Insider Activity

In other news, CEO Steven Sell bought 20,000 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was acquired at an average cost of $3.36 per share, with a total value of $67,200.00. Following the transaction, the chief executive officer now directly owns 67,590 shares in the company, valued at approximately $227,102.40. This trade represents a 0.00 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 3.20% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AGL. J.Safra Asset Management Corp grew its position in shares of agilon health by 626.1% during the 2nd quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company's stock valued at $27,000 after acquiring an additional 3,625 shares during the period. City State Bank purchased a new stake in shares of agilon health in the third quarter valued at approximately $52,000. CWM LLC raised its stake in shares of agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company's stock worth $59,000 after buying an additional 7,288 shares during the period. Nisa Investment Advisors LLC purchased a new position in shares of agilon health during the 2nd quarter valued at approximately $60,000. Finally, Bleakley Financial Group LLC acquired a new stake in agilon health in the 1st quarter valued at $65,000.

agilon health Stock Performance

AGL stock traded down $0.06 during midday trading on Wednesday, reaching $3.26. The stock had a trading volume of 4,005,756 shares, compared to its average volume of 4,962,609. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.36 and a current ratio of 1.36. The firm has a fifty day simple moving average of $4.01 and a two-hundred day simple moving average of $5.27. The stock has a market cap of $1.34 billion, a PE ratio of -4.79 and a beta of 0.54. agilon health has a 52-week low of $2.99 and a 52-week high of $20.37.

agilon health (NYSE:AGL - Get Free Report) last posted its earnings results on Tuesday, August 6th. The company reported ($0.07) EPS for the quarter, hitting the consensus estimate of ($0.07). The firm had revenue of $1.48 billion for the quarter, compared to analyst estimates of $1.56 billion. agilon health had a negative return on equity of 29.91% and a negative net margin of 5.57%. agilon health's revenue for the quarter was up 38.7% compared to the same quarter last year. During the same period last year, the company earned ($0.04) earnings per share. As a group, equities research analysts anticipate that agilon health will post -0.32 EPS for the current year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on AGL shares. Benchmark reiterated a "buy" rating and set a $9.00 price objective on shares of agilon health in a research note on Thursday, August 8th. Bank of America lowered agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price for the company. in a report on Wednesday, October 2nd. Royal Bank of Canada reiterated an "outperform" rating and issued a $8.00 price target on shares of agilon health in a report on Wednesday, August 7th. Evercore ISI dropped their price objective on agilon health from $7.00 to $4.00 and set an "in-line" rating on the stock in a research report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on agilon health from $5.00 to $4.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and four have assigned a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $8.03.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.